# Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a Pilot Study

> **NCT07391332** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Gambling Disorder

## Interventions

- **DRUG:** Psychotherapy assisted by high-dose psilocybin (25mg or 40mg where appropriate)
- **DRUG:** Psychotherapy assisted by low-dose psilocybin (1 mg)

## Key facts

- **NCT ID:** NCT07391332
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07391332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07391332, "Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07391332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*